Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Survival Comparability Between Thalassemia Major Versus Thalassemia Intermedia

Blood (2015) 126 (23): 2141.

https://doi.org/10.1182/blood.V126.23.2141.2141

Published: 2015

Journal Articles

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

Blood (2014) 124 (21): 1354.

https://doi.org/10.1182/blood.V124.21.1354.1354

Published: 2014

Journal Articles

CMR Survey In a Large Cohort Of TI Patients

Antonella Meloni, PhD, Maria-Eliana Lai, MD, Stefania Vacquer, MD, Roberto Mattei, MD, Crocetta Argento, MD, Domenico Maddaloni, MD, Aurelio Maggio, MD, Cristina Salvatori, Gennaro Restaino, MD, Vincenzo Positano, MSc, Massimo Lombardi, MD, Alessia Pepe, MD, PhD

Blood (2013) 122 (21): 1015.

https://doi.org/10.1182/blood.V122.21.1015.1015

Published: 2013

Journal Articles

Two-Year Renal Hemodynamic Effects of Deferasirox in Patients with Transfusion-Dependent β-Thalassemia

Antonio Piga, MD, Silvia Fracchia, MD, Maria Eliana Lai, MD, M Domenica Cappellini, MD, Dany Habr, MD, Antje Wegener, MD, Emmanuel Bouillaud, MSc, Gian Luca Forni, MD

Blood (2012) 120 (21): 3257.

https://doi.org/10.1182/blood.V120.21.3257.3257

Published: 2012

Journal Articles

Estimation of the Prevalence of Pulmonary Artery Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization

Giorgio Derchi, Renzo Galanello, MD, Patrizio Bina, Maria D Cappellini, Antonio Piga, MD, Maria-Eliana Lai, Antonella Quarta, Gavino Casu, Silverio Perrotta, Khaled M Musallam, Gian Luca Forni, MD

Blood (2012) 120 (21): 3262.

https://doi.org/10.1182/blood.V120.21.3262.3262

Published: 2012

Journal Articles

Right Ventricular Volumes and Function Normalized to Body Surface Area, Age and Sex in a Large Cohort of Well-Treated Thalassemia Major without Myocardial Iron Overload

Antonella Meloni, PhD, Giovanni Aquaro, Lamia Ait-Ali, Saveria Campisi, Domenico Giuseppe D'Ascola, Antonella Quarta, M.D., Pier Paolo Bitti, Gaetano Roccamo, M.D., Maria Grazia Bisconte, Basilia Piraino, Maria Eliana Lai, Angelo Peluso, Stefania Renne, Lucia De Franceschi, MD, Vincenzo Positano, Massimo Lombardi, Alessia Pepe

Blood (2011) 118 (21): 5293.

https://doi.org/10.1182/blood.V118.21.5293.5293

Published: 2011

Journal Articles

Heart T2* for Prediction of Cardiac Complications in Well-Treated TM Patients

Alessia Pepe, Antonella Meloni, PhD, Giuseppe Rossi, Paolo Cianciulli, M.D., Anna Spasiano, Domenico D'Ascola, Aurelio Maggio, MD, Domenico Maddaloni, Antonella Carollo, M.D., Michele Rizzo, M.D., Ketty Perrotta, M.D., Giuseppina Secchi, Maria Eliana Lai, Vincenzo Positano, Massimo Lombardi

Blood (2011) 118 (21): 1089.

https://doi.org/10.1182/blood.V118.21.1089.1089

Published: 2011

Journal Articles

Prospective Survey on Heart and Liver Iron and Heart Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine Versus Deferiprone and Desferrioxamine in Monotherapy

Alessia Pepe, Antonella Meloni, PhD, Giuseppe Rossi, Anna Spasiano, Domenico Giuseppe D'Ascola, Aldo Filosa, Vincenzo Caruso, M.D., Paolo Cianciulli, M.D., Maria Antonietta Romeo, M.D., Maria Caterina Putti, MD, Angelo Peluso, Maria Grazia Bisconte, Maria Eliana Lai, Aurelio Maggio, MD, Cristina Salvatori, Massimo Lombardi, Marcello Capra, M.D.

Blood (2011) 118 (21): 5298.

https://doi.org/10.1182/blood.V118.21.5298.5298

Published: 2011

Journal Articles

Feasibility, Reproducibility and Reliability for the T2* Iron Evaluation At 3T in Comparison with 1.5T

Antonella Meloni, PhD, Vincenzo Positano, Petra Keilberg, Daniele De Marchi, Pasquale Pepe, Angelo Zuccarelli, Saveria Campisi, Maria Antonietta Romeo, M.D., Tommaso Casini, Pier Paolo Bitti, Calogera Gerardi, M.D., Maria Eliana Lai, Basilia Piraino, Gaetano Giuffrida, Giuseppina Secchi, Lucia De Franceschi, MD, Massimo Midiri, Massimo Lombardi, Alessia Pepe

Blood (2011) 118 (21): 5301.

https://doi.org/10.1182/blood.V118.21.5301.5301

Published: 2011

Journal Articles

Amelioration of Sardinian β 0 thalassemia by genetic modifiers

Renzo Galanello, Serena Sanna, Lucia Perseu, Maria Carla Sollaino, Stefania Satta, Maria Eliana Lai, Susanna Barella, Manuela Uda, Gianluca Usala, Goncalo R. Abecasis, Antonio Cao

Blood (2009) 114 (18): 3935–3937.

https://doi.org/10.1182/blood-2009-04-217901

Published: 2009

Journal Articles

Cardiac and Liver Magnetic Resonance Characterization of Thalassemia Intermedia Patients: A Comparative Multicenter Study Versus Thalassemia Major Patients

Alessia Pepe, MD, PhD, Brunella Favilli, MSc, Anna Ramazzotti, PhD, Vincenzo Positano, MSc, Caterina Borgna-Pignatti, MD, Marcello Capra, MD, Maria-Eliana Lai, MD, Anna Spasiano, MD, Lorella Pitrolo, MD, Aldo Filosa, MD, Paolo Cianciulli, MD, Antonietta Mascolino, MD, Gaetano Giuffrida, MD, Gianluca Forni, MD, Aurelio Maggio, MD, Massimo Lombardi

Blood (2008) 112 (11): 5421.

https://doi.org/10.1182/blood.V112.11.5421.5421

Published: 2008

Journal Articles

Down Regulation of Hepcidin and Interleukin 1-Alpha in Pbmc from Patients with Beta thalassemia

Maria-Eliana Lai, Stefania Vacquer, Maria Paola Carta, Claudia Mulas, Pierluigi Cocco, Sandra Dessi

Blood (2008) 112 (11): 2880.

https://doi.org/10.1182/blood.V112.11.2880.2880

Published: 2008

Journal Articles

Multislice Multiecho T2* Cardiovascular Magnetic Resonance Detects Heterogeneous Myocardial Iron Distribution in Thalassemia Patients

Vincenzo Positano, MSc, Alessia Pepe, MD, PhD, Anna Ramazzotti, PhD, Maria Filomena Santarelli, PhD, Antonella Meloni, MSc, Anna Spasiano, MD, Caterina Borgna-Pignatti, MD, Paolo Cianciulli, MD, Marcello Capra, MD, Maria-Eliana Lai, MD, Aurelio Maggio, MD, Massimo Lombardi, MD, Luigi Landini, PhD

Blood (2008) 112 (11): 3877.

https://doi.org/10.1182/blood.V112.11.3877.3877

Published: 2008

Journal Articles

Effect of Iron Chelators on Cardiac Iron Assessed by MR T2* in Thalassemia Major

Renzo Galanello, MD, Antonio Piga, MD, Maria- Eliana Lai, MD, Gianluca Forni, MD, Fabrice Danjou, Filomena Longo, MD, Annalisa Agus, Raffaella Origa

Blood (2008) 112 (11): 3886.

https://doi.org/10.1182/blood.V112.11.3886.3886

Published: 2008

Journal Articles

Efficacy of the Novel Oral Iron Chelator Deferitrin in Metabolic Iron Balance Studies.

Robert W. Grady, PhD, Maria Sitarou, MD, Renzo Galanello, MD, Hannah Tamary, MD, Eliana Lai, MD, Aurelio Maggio, MD, Farrukh Shah, MD, Patricia J. Giardina, MD, Joanne M. Donovan, MD, PhD

Blood (2007) 110 (11): 2775.

https://doi.org/10.1182/blood.V110.11.2775.2775

Published: 2007

Journal Articles

Long-Term Outcome of Iron-Induced Cardiac Disease in Patients with Thalassemia Major Treated with Combined DFP/DFO or DFO Alone.

Maria Eliana Lai, MD, Stefania Vacquer, MD, Alessia Pepe, MD, Aurelio Maggio, MD, Maria P. Carta, MD, Paolo Cianciulli, MD, Patrizio Bina, MD, Franco Sau, MD, Robert W. Grady, PhD

Blood (2006) 108 (11): 1764.

https://doi.org/10.1182/blood.V108.11.1764.1764

Published: 2006

Journal Articles

Hydroxyurea to Increase Hemoglobin Level in Thalassemia Intermedia.

Donatella Baronciani, MD, Stefania Vaquer, MD, Paola Carta, MD, Eliana Lai, MD

Blood (2004) 104 (11): 3769.

https://doi.org/10.1182/blood.V104.11.3769.3769

Published: 2004

NARROW

Survival Comparability Between Thalassemia Major Versus Thalassemia Intermedia

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

CMR Survey In a Large Cohort Of TI Patients

Two-Year Renal Hemodynamic Effects of Deferasirox in Patients with Transfusion-Dependent β-Thalassemia

Estimation of the Prevalence of Pulmonary Artery Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization

Right Ventricular Volumes and Function Normalized to Body Surface Area, Age and Sex in a Large Cohort of Well-Treated Thalassemia Major without Myocardial Iron Overload

Heart T2* for Prediction of Cardiac Complications in Well-Treated TM Patients

Prospective Survey on Heart and Liver Iron and Heart Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine Versus Deferiprone and Desferrioxamine in Monotherapy

Feasibility, Reproducibility and Reliability for the T2* Iron Evaluation At 3T in Comparison with 1.5T

Amelioration of Sardinian β 0 thalassemia by genetic modifiers

Cardiac and Liver Magnetic Resonance Characterization of Thalassemia Intermedia Patients: A Comparative Multicenter Study Versus Thalassemia Major Patients

Down Regulation of Hepcidin and Interleukin 1-Alpha in Pbmc from Patients with Beta thalassemia

Multislice Multiecho T2* Cardiovascular Magnetic Resonance Detects Heterogeneous Myocardial Iron Distribution in Thalassemia Patients

Effect of Iron Chelators on Cardiac Iron Assessed by MR T2* in Thalassemia Major

Efficacy of the Novel Oral Iron Chelator Deferitrin in Metabolic Iron Balance Studies.

Long-Term Outcome of Iron-Induced Cardiac Disease in Patients with Thalassemia Major Treated with Combined DFP/DFO or DFO Alone.

Hydroxyurea to Increase Hemoglobin Level in Thalassemia Intermedia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only